Safety of calcium antagonists in patients with congestive heart failure
Open Access
- 31 December 1997
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 19, 92-113
- https://doi.org/10.1016/s0149-2918(97)80039-2
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Calcium channel antagonists in the treatment of coronary artery disease: Fundamental pharmacological properties relevant to clinical useProgress in Cardiovascular Diseases, 1996
- Patterns of Medication Use in Patients With Heart FailureSouthern Medical Journal, 1995
- Calcium channel blockers in heart failureJournal of the American College of Cardiology, 1993
- The role of calcium antagonists in the treatment of chronic heart failureEuropean Heart Journal, 1993
- Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy.Circulation, 1990
- Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: Comparison with nitroprussideJournal of the American College of Cardiology, 1985
- Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failureThe American Journal of Cardiology, 1984
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.Circulation, 1982
- Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazemThe American Journal of Cardiology, 1980